Mounjaro®
Starting from £179.99/mo
Start journey Learn moreExcess wind and bloating are among the most common complaints in the first weeks on Wegovy. Semaglutide slows the rate at which food leaves your stomach, and that delay gives gut bacteria more time to ferment what you've eaten — producing gas as a byproduct. For most people the problem peaks early and settles. It is still a prescription-only medicine, assessed individually by a clinician before it is supplied.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Wegovy (semaglutide) is a GLP-1 receptor agonist. One of its primary mechanisms is slowing gastric emptying — food moves from the stomach into the small intestine more slowly than usual. That is partly why appetite falls, but it also means undigested carbohydrates and fats spend longer in contact with the billions of bacteria in your lower gut. Those bacteria ferment the food and release gas. The result is bloating, belching, flatulence, or all three at once.
The semaglutide overview on this site covers the mechanism in more detail, and the NHS medicines page for semaglutide lists wind among the very common reported effects. You are not reacting badly in an unusual way, this is the pharmacology doing exactly what it says on the tin.
The timing matters too. Gas tends to be worst in the 24 to 48 hours after your weekly injection, when semaglutide levels in the blood are rising. Most people find the symptom quietens by mid-week, then returns briefly after the next dose. Knowing that rhythm can make it feel a lot less alarming.
Semaglutide creates the conditions for gas; what you eat determines how much. High-fat meals are the most reliable amplifier, fat already slows gastric emptying, so stacking a fatty meal on top of a drug that does the same thing compounds the delay considerably. Carbonated drinks add gas before digestion even starts. Eating large portions quickly means the stomach has more to handle all at once.
Certain carbohydrates ferment faster than others: onions, garlic, beans, lentils, cauliflower and apples are common culprits. Artificial sweeteners (sorbitol and mannitol in particular, found in some protein bars and diet sweets) pull water into the bowel and accelerate fermentation. Many people on Wegovy find a short-term reduction in these foods noticeably reduces bloating during the first weeks at each new dose.
Eating speed is underrated. Swallowing air while eating quickly contributes directly to belching. Slowing down (and chewing properly) reduces both the air intake and the digestive burden on a gut that is already working more slowly. One practical detail: keeping a small notebook in your bag for a fortnight to log what you ate before a bad episode helps identify your personal triggers faster than trial and error alone.
The starting dose of Wegovy exists in part because of gastrointestinal tolerability. Beginning at a lower level gives the gut time to adapt before the maintenance dose is reached. If gas and bloating are significant at a given dose, the prescriber's view (not self-adjustment) determines whether slowing the titration schedule makes sense. Changing your own dose timing is not advised, and the Patient Information Leaflet is the definitive reference for how and when to inject.
Some people find that injecting at night, just before sleep, means the peak semaglutide effect passes while they are resting and less aware of digestive discomfort. Others prefer morning. There is no single right answer; it is worth raising with the clinical team at your next review. For a wider picture of how the treatment fits into a weight-management plan, the weight-loss treatment overview sets out the options clearly.
If symptoms are severe, or if abdominal pain is persistent and radiates to the back, stop managing it at home and seek medical help promptly. That pattern can occasionally point to pancreatitis, a known but uncommon risk with GLP-1 medicines flagged in MHRA Drug Safety Updates. It is not the same as ordinary wind and bloating, and it warrants urgent clinical assessment.
For the majority of people, gas on Wegovy is a first-few-weeks problem at each dose level, not a permanent feature of treatment. The gut adapts. The microbiome shifts. Most accounts (consistent with the clinical trial data from the STEP programme) describe gastrointestinal side effects as most intense in weeks one to four, reducing substantially after that. A small number of people find symptoms persist at higher doses, and in those cases the conversation with the prescriber about whether the titration pace is right is important.
The fuller picture of Wegovy's side-effect profile is worth reading if you are weighing up whether the early discomfort is likely to be worthwhile longer term. If you are curious how well the treatment tends to work for others, reading about the experiences of people who have used Wegovy can give you a more grounded sense of what to expect. And if you want to know whether the gas you are experiencing is specifically a semaglutide effect rather than something else, this page on semaglutide and gas looks at the evidence in more detail.
If you have not yet started treatment and are trying to understand what to expect, or if you are considering switching from another GLP-1 medicine, a prescriber can give you a clear-eyed individual answer. It is also worth knowing that Wegovy can degrade if it is stored incorrectly, so checking your pen before use is a sensible habit. Our clinical team, described on the clinical team page, reviews every consultation personally. Start your free consultation to get a clinical view on whether Wegovy is right for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.